Date:11/11/2009

assets 133 (143) 271 248 Amortization 889 30 1,121 84 Depreciation 8,591 7,623 31,755 30,041 Pre-opening expenses 2,223 143 3,563 786 Share-based compensation expense 322 (485) 2,390 4,978 --- ---- ----- ----- Adjusted EBITDA $9,538 $11,530 $55,590 $74,810 ====== ======= ======= ======= The following table reconciles MedCath's diluted earnings per share from continuing operations as derived directly from MedCath's consolidated financial statements to Adjusted EPS from continuing operations for the three months ended September 30, 2009 and 2008. Twelve Months Three Months Ended Ended September September 30, 30, ------------------- ----------------- 2009 2008 2009 2008 ---- ---- ---- ---- Diluted earnings per share ($3.14) $0.01 ($2.96) $0.61 Add: Third party payor adjustments 0.04 0.02 0.12 0.03 Termination of management contract 0.03 - 0.03 - Impairment of goodwill 3.05 - 3.05 - Operating expense as previously disclosed - - 0.28 0.02 Share-based compensation expense 0.01 (0.01) 0.08 0.14 Pre-opening expense 0.05 - 0.09 0.02 ---- --- ---- ---- Adjusted diluted earnings per share $0.04 $
'/>"/>

SOURCE MedCath Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Related medicine technology :

1. MedCath Corporation to Hold Conference Call on Fourth Quarter Results
2. Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
3. Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation
4. Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
5. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
6. China National Medicines Corporation Issues Milestone Purchase Order for 12,000 STA Systems
7. China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou
8. DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
9. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
10. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
11. Select Medical Holdings Corporation Announces Exercise of Underwriters Option to Purchase Additional Shares